Invesco
LUMO

Invesco’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Invesco’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,638
Closed -$265K – 3745
2019
Q4 		$265K Sell
11,638
-769
-6% -$11K ﹤0.01% 3461
2019
Q3 		$178K Sell
12,407
-485
-4% -$7.12K ﹤0.01% 3567
2019
Q2 		$172K Sell
12,892
-445
-3% -$6.72K ﹤0.01% 3635
2019
Q1 		$232K Buy
+13,337
New +$199K ﹤0.01% 3588
2018
Q1 		– Sell
-1,595
Closed -$116K – 3780
2017
Q4 		$116K Buy
1,595
+59
+4% +$4.88K ﹤0.01% 3600
2017
Q3 		$141K Sell
1,536
-6,714
-81% -$515K ﹤0.01% 3593
2017
Q2 		$546K Buy
8,250
+6,851
+490% +$848K ﹤0.01% 3299
2017
Q1 		$303K Buy
+1,399
New +$200K ﹤0.01% 3504
2016
Q2 		– Sell
-15,874
Closed -$2.6M – 3729
2016
Q1 		$2.6M Sell
15,874
-6,930
-30% -$1.4M ﹤0.01% 2301
2015
Q4 		$7.47M Buy
22,804
+1,225
+6% +$399K ﹤0.01% 1624
2015
Q3 		$6.96M Buy
21,579
+5,721
+36% +$2.51M ﹤0.01% 1638
2015
Q2 		$6.32M Buy
15,858
+7,860
+98% +$3.34M ﹤0.01% 1809
2015
Q1 		$3.94M Buy
7,998
+3,890
+95% +$1.51M ﹤0.01% 2146
2014
Q4 		$1.47M Buy
+4,108
New +$1.22M ﹤0.01% 2704
2014
Q2 		– Sell
-33,447
Closed -$8.55M – 4094
2014
Q1 		$8.55M Buy
33,447
+1,393
+4% +$426K ﹤0.01% 1600
2013
Q4 		$6.35M Buy
32,054
+498
+2% +$88.6K ﹤0.01% 1838
2013
Q3 		$5.33M Buy
31,556
+701
+2% +$113K ﹤0.01% 1885
2013
Q2 		$5.48M Buy
+30,855
New +$4.37M ﹤0.01% 1784

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
IFG
Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invesco's LUMO Position: Q1 2020 in Review

Invesco sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 11,638 shares — an estimated $265K sold.

Invesco first reported a position in LUMO in Q2 2013 and held it in 18 quarters. The position peaked at $8.55M in Q1 2014. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

  • Invesco reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Invesco sold 11,638 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $265K.
  • Invesco first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
  • Invesco's Lumos Pharma, Inc. Common Stock position peaked at $8.55M in Q1 2014.
  • 46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Invesco's 13F filing for Q1 2020, filed 15 May 2020.